Excess mortality of schizophrenia: A meta-analysis

Cited by (869)

Items 601–700 of 869

1. Chapter 2. Changes in Schizophrenia Across Time: Paradoxes, Patterns, and Predictors
   Courtenay M. Harding · 2003 · American Psychiatric Association Publishing eBooks
2. Schizophrenia, Other Psychotic Disorders, and Suicidal Behavior
   Antoine Desîlets, Myriam Labossière, Alexander McGirr, Gustavo Turecki · 2016 · Wiley eBooks
3. Costi diretti della schizofrenia nei dipartimenti di salute mentale italiani
   Gruppo di Studio SCORE, Livio Garattini, Carlotta Rossi, Fabrizio Tediosi, C Cornaggia, Giampiero Covelli, Corrado Barbui, Fabio Parazzini · 2002 · PharmacoEconomics Italian Research Articles
4. COGNITIVE DYSFUNCTION IN SCHIZOPHRENIA: A FAMILIAL AND GENETIC APPROACH
   Annamari Tuulio‐Henriksson · 2005 · Työväentutkimus Vuosikirja
5. FitForLife: study protocol for a randomized controlled trial
   Yvonne Forsell, Mats Å. Hallgren, Maria Mattson, Örjan B. Ekblom, Catharina Lavebratt · 2015 · Trials
6. Depressive Temperament in Relatives of Patients with Schizophrenia Is Associated with Suicidality in Patients with Schizophrenia
   Esra Yazıcı, Zerrin Cimen, Ipen Ilknur Unlu Akyollu, Ahmet Bülent Yazıcı, Betul Aslan Turkmen, Atila Erol · 2018 · Clinical Psychopharmacology and Neuroscience
7. A reverse colocated integrated care model intervention among persons with severe persistent mental illness at the U.S.-Mexico border: A randomized controlled trial protocol
   Karen M. Sautter, M. Marlen Ramirez, Amy Flynn, Ziming Xuan · 2019 · Contemporary Clinical Trials Communications
8. SUICIDE ATTEMPTS AT THE TIME OF FIRST ADMISSION AND DURING EARLY COURSE SCHIZOPHRENIA: A POPULATION BASED STUDY
   Stephen Z. Levine, Shelly S. Bakst, Jonathan Rabinowitz · 2010 · Schizophrenia Research
9. The effect of ziprasidone on metabolic syndrome risk factors in subjects with schizophrenia: a 1 year, open-label, prospective study
   Pierre S. Chue, Francine S. Mandel, François Therrien · 2014 · Current Medical Research and Opinion
10. Acute care hospital mortality of schizophrenic patients
    Yasuharu Tokuda, Haruo Obara, Nobuhiko Nakazato, Gerald H. Stein · 2008 · Journal of Hospital Medicine
11. Continuity of medication management among adults with schizophrenia and comorbid cardiometabolic conditions
    Richard A. Hansen, Natalie S. Hohmann, Matthew L. Maciejewski, Marisa Elena Domino, Neepa Ray, Nirosha Mahendraratnam, Joel F. Farley · 2017 · Journal of Pharmaceutical Health Services Research
12. Audit of metabolic syndrome in adults prescribed clozapine in community and long-stay in-patient populations
    David Morgan, MATTHEW P. SARGEANT, Jude Chukwuma, Gwenllian Hughes · 2008 · Psychiatric Bulletin
13. Psychiatric and Neurological Disorders
    Vincenzo Catrambone, G. Valenza · 2021 · Functional Brain-Heart Interplay
14. Dislipidemias e antipsicóticos atípicos
    Edilberto Amorim, Fernanda de Sena Arandas, Irismar Reis de Oliveira, Eduardo Pondé de Sena · 2006 · Jornal Brasileiro de Psiquiatria
15. Chapter 3 The lipid hypothesis of schizophrenia
    David F. Horrobin · 2002 · New comprehensive biochemistry
16. Impact of Psychotic Disorders on Discharge Dispositions of Adults 65 or Older After a General Medical Inpatient Stay
    Sara Bressi Nath, Steven C. Marcus · 2012 · Psychiatric Services
17. Association of duration of treatment on post-discharge mortality in forensic psychiatric patients in Finland
    Ilkka Ojansuu, Jonas Forsman, Hannu Kautiainen, Allan Seppänen, Jari Tiihonen, Markku Lähteenvuo · 2024 · Frontiers in Psychiatry
18. Suicidal ideation in an Egyptian sample of hospitalized patients with acute psychosis
    Ahmed Mubarak, El-Sayed Abdel Hamid Gad, Sameh A. Saada, Maha Ftouh, Mohammad Abdel-Hakeem Seleem · 2020 · Psychosis
19. Establishing a Care Continuum for Cardiometabolic Conditions for Patients with Serious Mental Illness
    Karly A. Murphy, G. Daumit · 2023 · Current Cardiology Reports
20. Adapting the Comprehensive Unit Safety Program (CUSP) implementation strategy to increase delivery of evidence-based cardiovascular risk factor care in community mental health organizations: protocol for a pilot study
    Emma Elizabeth McGinty, David Thompson, Karly A. Murphy, Elizabeth A. Stuart, Nae‐Yuh Wang, Arlene Dalcin, Elizabeth Mace, Joseph V. Gennusa, Gail L. Daumit · 2021 · Implementation Science Communications
21. Open wide: a dental health and toothbrush exchange project at an inpatient recovery and rehabilitation unit
    Waqqas Ahmad Khokhar, Katherine Williams, Oluwagbenga Odeyemi, Tracy Clarke, Catharine Jane Tarrant, Andrew Clifton · 2011 · Mental Health Review Journal
22. Why do adults with schizophrenia have poorer physical health than the rest of the population
    Tim Bradshaw, Karina Lovell, Bee Pe, Hilary Mairs · 2005 · Mental Health Practice
23. Effect of a 30-Month Health-Promoting Program on the Prevalence of Cardiovascular Risk Factors in Patients With First Episode Schizophrenia
    Hans Jørgen Søgaard, Mikkel Højlund, Anja Friis Elliott, Anne Grethe Viuff, Kirsten Vandborg, Jakob Hansen Viuff, Povl Munk‐Jørgensen, Peter Hjorth · 2018 · American Journal of Therapeutics
24. Examining healthcare professionals’ beliefs and actions regarding the physical health of people with schizophrenia
    Alexandra Berry, Richard Drake, Alison Ruth Yung · 2020 · BMC Health Services Research
25. Identification of a High-risk Subgroup With Malignant Mitral Valve Prolapse Who Are Predisposed to Sudden Cardiac Death: A Review
    Ronald C. Russo, Abhishek Maan, Eirini Apostolidou, Arshia Khorasani-Zadeh, Sean Byrnes, Philip Chebaya, Robert Beale, Mohammad Usama Abbasi, Charles E. Beale · 2020 · Critical Pathways in Cardiology A Journal of Evidence-Based Medicine
26. Aberrant anterior cingulate processing of anticipated threat as a mechanism for psychosis
    Mark D. Kvarta, Joshua Chiappelli, Jeffrey West, Eric Luria Goldwaser, Heather A Bruce, Yizhou Ma, Peter Kochunov, Kathryn S. Hatch, Si Gao, Aaron Jones et al. · 2021 · Psychiatry Research Neuroimaging
27. Reducing cardiovascular risk factors in non-selected outpatients with schizophrenia
    M. V. Hansen, P. Hjorth, C. Kristiansen, Kirsten Vandborg, L. N. Gustafsson, P. Munk-Jørgensen · 2016 · International Journal of Social Psychiatry
28. Mortality among patients with schizophrenia and vocational rehabilitation program services under Taiwan’s psychiatric care reform
    Kan-Yuan Cheng, Shuyuan Chen, Chih‐Yuan Lin · 2016 · International Journal of Mental Health Systems
29. Cardiometabolic Risk and Monitoring in Psychiatric Disorders
    Katherine Samaras · 2016 · Springer eBooks
30. National study comparing the characteristics of patients diagnosed with schizophrenia who committed homicide vs. those who died by suicide
    Alison Baird, Jenny J. Shaw, Isabelle M. Hunt, Navneet Kapur, Louis Appleby, Roger Thomas Webb · 2018 · Journal of Forensic Psychiatry and Psychology
31. Maladie cardiovasculaire et diabète chez les personnes atteintes d’une maladie mentale sévère
    André Jacques Scheen, B. Gillain, M. De Hert · 2010 · Médecine des Maladies Métaboliques
32. Maintaining physical health in severe mental illness
    Sheila Hardy · 2009 · Independent Nurse
33. Physical health and dual diagnosis
    Debbie Robson, Sarah Keen, Pia M. Mauro · 2008 · Advances in Dual Diagnosis
34. Influence of Antipsychotic Agents on Heart Rate Variability in Male WKY Rats: Implications for Cardiovascular Safety
    Ying-Chieh Wang, Chun-Yu Chen, Terry B.J. Kuo, Ching-Jung Lai, Cheryl C.H. Yang · 2012 · Neuropsychobiology
35. Dysphagia and Chronic Mental Illness
    Jeffrey G. Stovall, Lisa S. Gussak · 2001 · The Primary Care Companion For CNS Disorders
36. WITHDRAWN: Maladie cardiovasculaire et diabète chez les sujets souffrant d’une maladie mentale sévère. Déclaration de position de l’European Psychiatric Association (EPA), soutenue par l’European Association for the Study of Diabetes (EASD) et l’European Society of Cardiology (ESC)
    M.A.F. De Hert, J.M. Dekker, D. Wood, K.G. Kahl, Richard I. G. Holt, Holger Jon Møller · 2010 · European Psychiatry
37. Health Promotion as Brief Treatment: Strategies for Women with Co-morbid Health and Mental Health Conditions
    Vikki L. Vandiver · 2007 · Brief Treatment and Crisis Intervention
38. The metabolic implications of long term cannabis use in patients with psychosis
    Farrah Mushtaq, Valeria Mondelli, Carmine Maria Pariante · 2008 · Epidemiologia e Psichiatria Sociale
39. No Effect of Adjunctive Minocycline Treatment on Body Metabolism in Patients With Schizophrenia
    Fang Liu, Liqin Xie, Bingkui Zhang, Ye Ruan, Yong Zeng, Xiufeng Xu, Jingping Zhao, Xiaoduo Fan · 2018 · Journal of Clinical Psychopharmacology
40. Psychische Krankheit als soziales Problem
    Reinhold Kilian · 2012 · VS Verlag für Sozialwissenschaften eBooks
41. Suicide Prevention in Early Psychosis
    Paddy Power · 2010 · Wiley eBooks
42. Metabolic Adverse Effects Associated with Antipsychotic Medications
    John W. Newcomer, Stefan Leucht · 2010 · Wiley eBooks
43. Psychische Störungen und internistische Erkrankungen
    Walter Hewer · 1999 · Springer eBooks
44. Differences between subjective experiences and observed behaviors in near-fatal suicide attempters with untreated schizophrenia: a qualitative pilot study
    Taiju Yamaguchi, Chiyo Fujii, Takahiro Nemoto, Naohisa Tsujino, Kiyoaki Takeshi, Masafumi Mizuno · 2015 · Annals of General Psychiatry
45. Genetic predisposition of BDNF (rs6265) gene is susceptible to Schizophrenia: A prospective study and updated meta-analysis
    M. Vajagathali, V. Ramakrishnan · 2024 · Neurología (English Edition)
46. Psychotropic Medications, Associated QTc Prolongation, and Sudden Cardiac Death: A Review for Clinicians
    Marley Doyle, Lisa J. Rosenthal · 2013 · Psychiatric Annals
47. Is adenosine associated with sudden death in schizophrenia? A new framework linking the adenosine pathway to risk of sudden death
    Ary Gadelha, André Zugman, Mariana Bendlin Calzavara, Remo Holanda de Mendonça Furtado, Fulvio Alexandre Scorza, Rodrigo A. Bressan · 2017 · Neuroscience & Biobehavioral Reviews
48. Application of SWATH mass spectrometry in the identification of circulating proteins does not predict future weight gain in early psychosis
    Adrian Hugh Heald, Narges Azadbakht, Bethany Geary, Silke Conen, Helene Fachim, Dave Chi Hoo Lee, Nophar Geifman, Sanam Farman, Oliver David Howes, Anthony David Whetton et al. · 2020 · Clinical Proteomics
49. Dynamic Patterns of Symptoms and Functioning in Predicting Deliberate Self-harm in Patients with First-Episode Schizophrenia-Spectrum Disorders Over 3 Years
    Ting Yat Wong, Sherry Kit Wa Chan, Charlton Cheung, Christy Lai Ming Hui, Yi Nam Suen, Wing Chung Chang, Edwin Ho Ming Lee, Eric Yu Hai Chen · 2022 · Schizophrenia Bulletin
50. The Mediating Role of Health-Promoting Behaviors on the Association between Symptom Severity and Quality of Life among Chinese Individuals with Mental Illness: A Cross-Sectional Study
    Phoenix K. H. Mo, Georgina Y. K. So, Zhihui Lu, Winnie W. S. Mak · 2022 · Psychopathology
51. Treatment and Mortality Following Cancer Diagnosis Among People With Non-affective Psychotic Disorders in Ontario, Canada: A Retrospective Cohort Study
    Jared C Wootten, Lucie Richard, Melody Lam, Phillip Blanchette, Marco Solmi, Kelly K. Anderson · 2024 · Schizophrenia Bulletin
52. Somatische Komorbidität im stationär psychiatrischen Bereich – eine Analyse administrativer Daten
    Fabian Friedrich, Zsuzsa Litvan, Marion Freidl · 2015 · Neuropsychiatrie
53. New Targets for the Management of Schizophrenia
    N. Dilbaz · 2015 · Klinik Psikofarmakoloji Bülteni-Bulletin of Clinical Psychopharmacology
54. Prise en charge des comorbidités cardio-vasculaires chez les jeunes patients souffrant d’une psychose débutante : état des lieux et perspectives thérapeutiques
    Ariel Frajerman, V. Morin, Boris Chaumette, Oussama Kébir, Marie‐Odile Krebs · 2020 · L Encéphale
55. Nursing Home Care for Adults With Chronic Schizophrenia
    Kirsten Donovan, Cheryl Regehr, Miriam George · 2012 · Social Work in Mental Health
56. Prevalence and Impact of Medical Disorders in Hospitalized Psychiatric Patients with Comorbid Substance Use Disorders
    John W Ceilley, Antoine B. Douaihy, Ihsan M. Salloum · 2005 · Addictive Disorders & Their Treatment
57. The Importance of Exercise for Individuals with Chronic Mental Illness
    Mary Weber · 2010 · Journal of Psychosocial Nursing and Mental Health Services
58. Elaborating the social brain hypothesis of schizophrenia
    Jonathan Kenneth Burns · 2004 · Behavioral and Brain Sciences
59. Tobacco smoking in persons with schizophrenia followed up at a teaching hospital in Sri Lanka
    N. Edrisinghe, Chamara Wijesinghe, Shehan Williams, K. A. L. A. Kuruppuarachchi · 2014 · Sri Lanka Journal of Psychiatry
60. Risk excess of mortality and use of antipsychotics
    Luis H. Martín Arias, Carlos Treceño Lobato, Susana Pérez García, María Sáinz-Gil, Rosario Sanz Fadrique, Pilar García Ortega · 2016 · International Clinical Psychopharmacology
61. Serum peroxisome proliferator-activated receptor-gamma levels in acute phase of male patients with schizophrenia and their relationship with metabolic parameters
    Tevfik Kalelioğlu, Nurdan Durak, Nesrin Karamustafalıoğlu, Abdullah Genç, Mustafa Akkuş, Akif Tasdemir, Mehmet Cem İlnem · 2017 · Psychiatry and Clinical Psychopharmacology
62. Genetic predisposition of BDNF (rs6265) gene is susceptible to Schizophrenia: A prospective study and updated meta-analysis
    Vajagathali Mohammed, Ramakrishnan Veerabathiran · 2022 · Neurología
63. Introduction
    David Martin Gardner, Michael D. Teehan, Ross J. Baldessarini · 2010 · Cambridge University Press eBooks
64. Risk of QT Prolongation and Torsades de Pointes with Psychotropic Drugs
    FRCP A. John Camm, MRCP Yee Guan Yap MB, Marek Malík · 2004
65. Recently evolved human-specific methylated regions are enriched in schizophrenia signals
    Niladri Banerjee, Tatiana Polushina, Francesco Bettella, Sudheer Giddaluru, Vidar M. Steen, Ole A. Andreassen, Stephanie Le Hellard · 2017 · bioRxiv (Cold Spring Harbor Laboratory)
66. Risperidone vs olanzapina: un confronto di costo e di risultato nel trattamento ospedaliero della schizofrenia (Studio RODOS)
    Roberto Ravasio, E Arrighi, A. Bitetto, D. Linciano, Antonio Lora, M. Sacchi, A. Voltolini · 2003 · PharmacoEconomics Italian Research Articles
67. The Impact of Adjunctive Aripiprazole on Olanzapine‐Induced Metabolic Adverse Effects in Patients With Schizophrenia: A Systematic Review
    Stephen Simmons, Soban Sadiq · 2025 · Neuropsychopharmacology Reports
68. Suicidal Ideation in an Egyptian Sample of Hospitalized Patients with Acute Psychosis
    Maha Ftouh, El-Sayed Abdel Hamid Gad, Mohammad Abdel-Hakeem Seleem, Sameh A. Saada, Ahmed Mubarak · 2017 · Clinical Schizophrenia & Related Psychoses
69. Effect of substituents on 3(S)-amino-1-hydroxy-3,4-dihydroquinolin-2(1H)-one: a DFT study
    Jerónimo Lira, Diego Ernesto Valencia, Haruna Luz Barazorda-Ccahuana, Jaime Cárdenas-Garcia, Badhin Gómez · 2019 · Theoretical Chemistry Accounts
70. Antipsychotic drug prescription sequence analysis in relation to death occurrence and cardiometabolic drug usage: A retrospective longitudinal study
    Paweł Zagożdżon, Piotr Dorozynski, Przemyslaw Maciej Waszak, Adam Harasimowicz, Tomasz Dziubich · 2022 · The European Journal of Psychiatry
71. Exploring the potential prognostic effect of various country‐specific health service data on all‐cause mortality using data from a large prospective study in schizophrenia
    Aurélia Mittoux, Per Tanghøj, Nicholas D Moore · 2012 · Pharmacoepidemiology and Drug Safety
72. Familial and sporadic schizophrenia: a comparison of somatic diseases and abuse in patients and their relatives
    Kristina I. Melkersson · 2008 · Acta Neuropsychiatrica
73. LORSQUE PIAGET, SIEGLER ET FLYNN RENCONTRENT DARWIN
    Serge J. Larivée · 2017 · Revue québécoise de psychologie
74. Körperliche Erkrankungen bei psychiatrischen Patienten
    Walter Hewer, H. Füeßl, Leo Hermle · 2011 · Fortschritte der Neurologie · Psychiatrie
75. Rethinking schizophrenia through the lens of evolution: shedding light on the enigma
    Ariel Ernesto Cariaga-Martínez, Kilian Gutiérrez, Raúl Alelú‐Paz · 2018 · Research Ideas and Outcomes
76. Atypical Antipsychotic Medications Disrupt the Cardio-Metabolic and Cardio-Immune Axes
    Bahman Rostama, Meghan A. May, KL Houseknecht · 2020 · Interventional Cardiology
77. Comorbidity between cannabis use and psychosis: modelling some possible relationships
    Louisa J Degenhardt, Wayne Hall, Michael T. Lynskey · 2001
78. Chapter 1. Patterns of Care for Persons 65 Years and Older With Schizophrenia
    Donna D. McAlpine · 2003 · American Psychiatric Association Publishing eBooks
79. Treatment gaps and knowledge gaps in mental health
    Assen V Jablensky · 2013
80. Towards an integration of evolutionary psychology and developmental science. New insights from evolutionary developmental biology
    Annemie Ploeger · 2008 · Data Archiving and Networked Services (DANS)
81. Die Behandlung gewalttätiger psychisch Kranker - eine Spezialaufgabe der forensischen Psychiatrie?
    Hans Schanda · 2005 · Journal für Kardiologie (Krause & Pachernegg GmbH)
82. Long-Term Functional Psychosis : Epidemiology in Two Different Counties in Sweden
    Birgitta Widerlöv · 2007 · Uppsala University Publications (Uppsala University)
83. Schizophrenia, Other Psychotic Disorders, and Suicidal Behaviour
    Alexander McGirr, Gustavo Turecki · 2011 · Wiley eBooks
84. Chapter 7. Medical Comorbidity in Older Persons With Schizophrenia
    Raymelle Schoos, Carl I. Cohen · 2003 · American Psychiatric Association Publishing eBooks
85. Molecular Genetics of Schizophrenia and Comorbid and Related Traits
    Jesper Ekelund · 2001 · Työväentutkimus Vuosikirja
86. Aripiprazole use and lowering the risk of breast cancer in patient with schizophrenia in a national cohort study
    Po‐Hsun Hou, Gung-Ruei Chang, Ying‐Ting Chao, Yu-Teng Chang, Da-Han Hou, Shiau‐Shian Huang · 2025 · PLoS ONE
87. Operation recovery: a feasibility study of an 8 week exercise and lifestyle programme within an Irish first episode psychosis service
    Claire Kearns Murphy, Louise Kemps, Catherine McDonough, Suzanne McDonough · 2022 · Irish Journal of Occupational Therapy
88. Video consultation and treatment in the community smoking cessation therapy success rates in patients with mental illness: a randomized controlled trial
    Didde Marie Kaasgaard, Mette Knudsgaard Sørensen, Rikke Bleeg Christiansen, Uffe Nymark Breum, Nestor Asiamah, Lone Bülow Toft Friis, Peter Hjorth · 2024 · Nordic Journal of Psychiatry
89. Waist circumference does not predict insulin resistance in African American schizophrenia patients
    Bernice B. Rumala, Xiaoduo Fan, Bikash Sharma, Dana Diem Nguyen, Christina P. C. Borba, Leah B. Namey Briggs, Sharon Forstbauer, Kate Miley, David C. Henderson · 2008 · International Journal of Culture and Mental Health
90. „Psychochirurgie“ und tiefe Hirnstimulation mit psychiatrischer Indikation
    M. Arends, Heiner Fangerau, Georg Winterer · 2009 · Der Nervenarzt
91. Schizophrenia and the Metabolic Syndrome
    Jared Edward Reser · 2011 · Springer eBooks
92. Les perturbations métaboliques liées à la prise d’antipsychotiques de seconde génération : revue de littérature et prise en charge
    Joëlle Flamand-Villeneuve · 2010 · Pharmactuel
93. L’enjeu de la mortalité dans la schizophrénie
    Emmanuelle Corruble · 2008 · Therapies
94. Point prevalence of diabetes, obesity, hyperlipidaemia, hypertension and smoking in outpatients on clozapine
    Larkin Feeney, Fiona Kelly, Judy J. Lee, Elizabeth Kelly, Sheila McLaughlin, James H O'Boyle · 2007 · Irish Journal of Psychological Medicine
95. Schizophrenia: Improving the Continuity of Care to Ensure Optimal Patient Outcomes
    Vladan Novakovic, Robert L. Barkin, Mark B. Hamner, Kathleen LeClear O’Connell · 2012 · Disease-a-Month
96. Physical health in schizophrenia
    Nadeem Mazi-Kotwal, Baljit Kaur Upadhyay · 2011 · Cutting Edge Psychiatry in Practice
97. Metabolic syndrome in relation to psychotropic polypharmacy
    P. Steylen, Frank van der Heijden, H. Kok, N. Sijben, Willem M. A. Verhoeven · 2012 · EUR Research Repository (Erasmus University Rotterdam)
98. Association of the type 2 diabetes mellitus susceptibility gene (IGF2BP2) with schizophrenia in an Egyptian sample
    Mohamed El Sayed El Taweel, Ahmed Abdalla Ali · 2017 · Middle East Current Psychiatry
99. Abnormalities in Glucose Blood Level during Antipsychotic Treatment in Schizophrenia Patients
    Faisal Idrus, Theodorus Singara, Dwiwahyu Sunarto, Saidah Syamsuddin, Sonny Teddy Lisal · 2021 · Open Access Macedonian Journal of Medical Sciences
100. Antipsychotic Medication–Induced Weight Gain and Risk for Diabetes and Cardiovascular Disease
     John W. Newcomer · 2007 · Humana Press eBooks